| 0.1 |
0.9 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.1 |
0.5 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.1 |
0.2 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 |
0.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.2 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 |
0.2 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.0 |
0.4 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.2 |
GO:0048389 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) deltoid tuberosity development(GO:0035993) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.0 |
0.1 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.0 |
0.3 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.0 |
0.2 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.0 |
0.3 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.0 |
0.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.1 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 |
0.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 |
0.1 |
GO:1905045 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.0 |
0.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.1 |
GO:0048867 |
ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.0 |
0.1 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.0 |
0.1 |
GO:1901297 |
positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.0 |
0.1 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.6 |
GO:0002691 |
regulation of cellular extravasation(GO:0002691) |
| 0.0 |
0.1 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 |
0.0 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.0 |
0.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
0.2 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.0 |
0.0 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.0 |
0.1 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.0 |
0.1 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.0 |
0.1 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.0 |
0.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.0 |
0.0 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
